Executive Chairman LoPriore Invests $500K in Hepion's Private Placement
CTRVP is trading near its 52-week low of $0.001 (0.0% above the low).
Summary
Hepion Pharmaceuticals' Executive Chairman Vincent S. LoPriore invested $500,000 in the company's private placement, acquiring 20 million shares and 10 million warrants.
Key Events · Ownership and Investor Activity · CTRVP
-
Chairman Invests $500K
Executive Chairman Vincent S. LoPriore acquired 20,000,000 shares at $0.05 per share for $500,000 in the private placement.
-
Warrants Included
LoPriore also received 10,000,000 warrants with a $0.06 exercise price, expiring August 3, 2031.
-
Insider Alignment
The purchase represents a significant personal commitment from a key executive, aligning his interests with shareholders.
-
Financial Distress Context
The company recently reported substantial doubt about its ability to continue as a going concern, making this insider investment a notable vote of confidence.
Analysis · CTRVP · Life Sciences
Executive Chairman Vincent S. LoPriore personally acquired 20 million shares at $0.05 per share for $500,000 in the company's recent private placement, alongside 10 million warrants exercisable at $0.06. This is a significant insider commitment from a key executive, representing a substantial portion of the company's market capitalization and aligning his interests with shareholders during a period of financial distress.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 34.7% of the 1013 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CTRVP was trading at $0.00 on OTC in the Life Sciences sector, with a market capitalization of approximately $1.5M. The 52-week trading range was $0.00 to $0.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.